New in Acute Graft-Versus-Host Disease

Nahla AM Hamed
Additional contact information
Nahla AM Hamed: Faculty of Medicine, Alexandria University, Egypt

Cancer Therapy & Oncology International Journal, 2018, vol. 9, issue 4, 118-121

Abstract: Life-threatening complications, such as GVHD, infection, conditioning regimen-related toxicities, and transplant-associated thrombotic microangiopathy are limiting factors for the clinical application of the HCT. They are more common in patients receiving HLA locus mismatched grafts.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555770.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555770.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:9:y:2018:i:4:p:118-121

DOI: 10.19080/CTOIJ.2018.09.555770

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().